285 related articles for article (PubMed ID: 33269467)
1. Topical corticosteroids normalize both skin and systemic inflammatory markers in infant atopic dermatitis.
McAleer MA; Jakasa I; Stefanovic N; McLean WHI; Kezic S; Irvine AD
Br J Dermatol; 2021 Jul; 185(1):153-163. PubMed ID: 33269467
[TBL] [Abstract][Full Text] [Related]
2. Systemic and stratum corneum biomarkers of severity in infant atopic dermatitis include markers of innate and T helper cell-related immunity and angiogenesis.
McAleer MA; Jakasa I; Hurault G; Sarvari P; McLean WHI; Tanaka RJ; Kezic S; Irvine AD
Br J Dermatol; 2019 Mar; 180(3):586-596. PubMed ID: 30132823
[TBL] [Abstract][Full Text] [Related]
3. Children with atopic dermatitis show increased activity of β-glucocerebrosidase and stratum corneum levels of glucosylcholesterol that are strongly related to the local cytokine milieu.
Kezic S; McAleer MA; Jakasa I; Goorden SMI; der Vlugt KG; Beers-Stet FS; Meijer J; Roelofsen J; Nieman MM; van Kuilenburg ABP; Irvine AD
Br J Dermatol; 2022 Jun; 186(6):988-996. PubMed ID: 34993951
[TBL] [Abstract][Full Text] [Related]
4. A minimally invasive tool to study immune response and skin barrier in children with atopic dermatitis.
Hulshof L; Hack DP; Hasnoe QCJ; Dontje B; Jakasa I; Riethmüller C; McLean WHI; van Aalderen WMC; Van't Land B; Kezic S; Sprikkelman AB; Middelkamp-Hup MA
Br J Dermatol; 2019 Mar; 180(3):621-630. PubMed ID: 29989151
[TBL] [Abstract][Full Text] [Related]
5. Skin tape sampling technique identifies proinflammatory cytokines in atopic dermatitis skin.
Lyubchenko T; Collins HK; Goleva E; Leung DYM
Ann Allergy Asthma Immunol; 2021 Jan; 126(1):46-53.e2. PubMed ID: 32896640
[TBL] [Abstract][Full Text] [Related]
6. Stratum corneum markers of innate and T helper cell-related immunity and their relation to the disease severity in Croatian patients with atopic dermatitis.
Jurakic Toncic R; Jakasa I; Sun Y; Hurault G; Ljubojevic Hadzavdic S; Tanaka RJ; Pavicic B; Balic A; Zuzul K; Petkovic M; Kezic S; Marinovic B
J Eur Acad Dermatol Venereol; 2021 May; 35(5):1186-1196. PubMed ID: 33480075
[TBL] [Abstract][Full Text] [Related]
7. Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic Dermatitis.
Guttman-Yassky E; Diaz A; Pavel AB; Fernandes M; Lefferdink R; Erickson T; Canter T; Rangel S; Peng X; Li R; Estrada Y; Xu H; Krueger JG; Paller AS
JAMA Dermatol; 2019 Dec; 155(12):1358-1370. PubMed ID: 31596431
[TBL] [Abstract][Full Text] [Related]
8. Exploring Immune Development in Infants With Moderate to Severe Atopic Dermatitis.
Hulshof L; Overbeek SA; Wyllie AL; Chu MLJN; Bogaert D; de Jager W; Knippels LMJ; Sanders EAM; van Aalderen WMC; Garssen J; Van't Land B; Sprikkelman AB;
Front Immunol; 2018; 9():630. PubMed ID: 29966024
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis.
Nakazato J; Kishida M; Kuroiwa R; Fujiwara J; Shimoda M; Shinomiya N
Pediatr Allergy Immunol; 2008 Nov; 19(7):605-13. PubMed ID: 18266834
[TBL] [Abstract][Full Text] [Related]
10. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
Furukawa H; Takahashi M; Nakamura K; Kaneko F
J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
[TBL] [Abstract][Full Text] [Related]
11. Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis.
Beck LA; Cork MJ; Amagai M; De Benedetto A; Kabashima K; Hamilton JD; Rossi AB
JID Innov; 2022 Sep; 2(5):100131. PubMed ID: 36059592
[TBL] [Abstract][Full Text] [Related]
12. Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab: A study protocol.
Nakahara T; Izuhara K; Onozuka D; Nunomura S; Tamagawa-Mineoka R; Masuda K; Ichiyama S; Saeki H; Kabata Y; Abe R; Ohtsuki M; Kamiya K; Okano T; Miyagaki T; Ishiuji Y; Asahina A; Kawasaki H; Tanese K; Mitsui H; Kawamura T; Takeichi T; Akiyama M; Nishida E; Morita A; Tonomura K; Nakagawa Y; Sugawara K; Tateishi C; Kataoka Y; Fujimoto R; Kaneko S; Morita E; Tanaka A; Hide M; Aoki N; Sano S; Matsuda-Hirose H; Hatano Y; Takenaka M; Murota H; Katoh N; Furue M
Medicine (Baltimore); 2020 Sep; 99(38):e22043. PubMed ID: 32957324
[TBL] [Abstract][Full Text] [Related]
13. Altered Levels of Sphingosine, Sphinganine and Their Ceramides in Atopic Dermatitis Are Related to Skin Barrier Function, Disease Severity and Local Cytokine Milieu.
Toncic RJ; Jakasa I; Hadzavdic SL; Goorden SM; Vlugt KJG; Stet FS; Balic A; Petkovic M; Pavicic B; Zuzul K; Marinovic B; Kezic S
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183011
[TBL] [Abstract][Full Text] [Related]
14. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency.
Kezic S; O'Regan GM; Lutter R; Jakasa I; Koster ES; Saunders S; Caspers P; Kemperman PM; Puppels GJ; Sandilands A; Chen H; Campbell LE; Kroboth K; Watson R; Fallon PG; McLean WH; Irvine AD
J Allergy Clin Immunol; 2012 Apr; 129(4):1031-9.e1. PubMed ID: 22322004
[TBL] [Abstract][Full Text] [Related]
15. Assessment of biomarkers in pediatric atopic dermatitis by tape strips and skin biopsies.
Andersson AM; Sølberg J; Koch A; Skov L; Jakasa I; Kezic S; Thyssen JP
Allergy; 2022 May; 77(5):1499-1509. PubMed ID: 34695223
[TBL] [Abstract][Full Text] [Related]
16. The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults.
Renert-Yuval Y; Del Duca E; Pavel AB; Fang M; Lefferdink R; Wu J; Diaz A; Estrada YD; Canter T; Zhang N; Wagner A; Chamlin S; Krueger JG; Guttman-Yassky E; Paller AS
J Allergy Clin Immunol; 2021 Jul; 148(1):148-163. PubMed ID: 33453290
[TBL] [Abstract][Full Text] [Related]
17. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity.
Chamlin SL; Kao J; Frieden IJ; Sheu MY; Fowler AJ; Fluhr JW; Williams ML; Elias PM
J Am Acad Dermatol; 2002 Aug; 47(2):198-208. PubMed ID: 12140465
[TBL] [Abstract][Full Text] [Related]
18. NOD2 Agonism Counter-Regulates Human Type 2 T Cell Functions in Peripheral Blood Mononuclear Cell Cultures: Implications for Atopic Dermatitis.
Gimenez-Rivera VA; Patel H; Dupuy FP; Allakhverdi Z; Bouchard C; Madrenas J; Bissonnette R; Piccirillo CA; Jack C
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830738
[TBL] [Abstract][Full Text] [Related]
19. Pyrrolidone carboxylic acid levels or caspase-14 expression in the corneocytes of lesional skin correlates with clinical severity, skin barrier function and lesional inflammation in atopic dermatitis.
Jung M; Choi J; Lee SA; Kim H; Hwang J; Choi EH
J Dermatol Sci; 2014 Dec; 76(3):231-9. PubMed ID: 25315296
[TBL] [Abstract][Full Text] [Related]
20. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis.
Kagami S; Kakinuma T; Saeki H; Tsunemi Y; Fujita H; Nakamura K; Takekoshi T; Kishimoto M; Mitsui H; Torii H; Komine M; Asahina A; Tamaki K
Clin Exp Immunol; 2003 Nov; 134(2):309-13. PubMed ID: 14616792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
